An official website of the United States government
2013 BRFSS Asthma Call-Back Survey Prevalence Tables
TABLE 8b. Estimated percent advised to make environmental changes for active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013
| State/Territory | Active | Inactive | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 139 | 37.9 | 8.9 | (20.5 – 55.3) | 27 | N/A | N/A | (N/A – N/A) |
| Arizona | 106 | 39.1 | 11.7 | (16.2 – 62.0) | 26 | N/A | N/A | (N/A – N/A) |
| California | 183 | 40.9 | 6.2 | (28.7 – 53.1) | 80 | N/A | N/A | (N/A – N/A) |
| Connecticut | 233 | 35.4 | 6.3 | (23.1 – 47.7) | 66 | 47.2 | 13.8 | (20.2 – 74.2) |
| Florida | 771 | 43.2 | 5.6 | (32.2 – 54.2) | 219 | N/A | N/A | (N/A – N/A) |
| Georgia | 133 | 38.5 | 7.6 | (23.6 – 53.4) | 52 | N/A | N/A | (N/A – N/A) |
| Hawaii | 110 | N/A | N/A | (N/A – N/A) | 68 | N/A | N/A | (N/A – N/A) |
| Indiana | 338 | 33.4 | 4.5 | (24.6 – 42.2) | 83 | 34.3 | 9.9 | (14.9 – 53.7) |
| Iowa | 212 | 25.8 | 5.2 | (15.6 – 36.0) | 66 | N/A | N/A | (N/A – N/A) |
| Kansas | 659 | 32.8 | 3.6 | (25.7 – 39.9) | 147 | 32.5 | 8.1 | (16.6 – 48.4) |
| Kentucky | 364 | 44.8 | 4.9 | (35.2 – 54.4) | 45 | N/A | N/A | (N/A – N/A) |
| Louisiana | 144 | 24.7 | 6.5 | (12.0 – 37.4) | 33 | N/A | N/A | (N/A – N/A) |
| Maine | 241 | 34.9 | 5.5 | (24.1 – 45.7) | 46 | N/A | N/A | (N/A – N/A) |
| Maryland | 247 | 34.5 | 5.0 | (24.7 – 44.3) | 54 | N/A | N/A | (N/A – N/A) |
| Massachusetts | 151 | 33.7 | 7.8 | (18.4 – 49.0) | 33 | N/A | N/A | (N/A – N/A) |
| Michigan | 493 | 41.8 | 4.0 | (34.0 – 49.6) | 82 | 28.0 | 8.3 | (11.7 – 44.3) |
| Mississippi | 214 | 30.2 | 7.1 | (16.3 – 44.1) | 52 | N/A | N/A | (N/A – N/A) |
| Missouri | 221 | 50.3 | 6.3 | (38.0 – 62.6) | 54 | 47.8 | 11.4 | (25.5 – 70.1) |
| Montana | 278 | 36.9 | 7.6 | (22.0 – 51.8) | 65 | N/A | N/A | (N/A – N/A) |
| Nebraska | 288 | 24.4 | 5.6 | (13.4 – 35.4) | 70 | N/A | N/A | (N/A – N/A) |
| Nevada | 111 | N/A | N/A | (N/A – N/A) | 38 | N/A | N/A | (N/A – N/A) |
| New Hampshire | 227 | 39.7 | 6.4 | (27.2 – 52.2) | 54 | 44.3 | 11.7 | (21.4 – 67.2) |
| New Jersey | 283 | 43.5 | 6.2 | (31.3 – 55.7) | 47 | N/A | N/A | (N/A – N/A) |
| New Mexico | 238 | 46.8 | 6.0 | (35.0 – 58.6) | 56 | N/A | N/A | (N/A – N/A) |
| New York | 112 | 31.3 | 7.0 | (17.6 – 45.0) | 34 | N/A | N/A | (N/A – N/A) |
| North Carolina | 123 | 40.5 | 7.7 | (25.4 – 55.6) | 22 | N/A | N/A | (N/A – N/A) |
| Ohio | 257 | 30.2 | 5.6 | (19.2 – 41.2) | 57 | N/A | N/A | (N/A – N/A) |
| Oklahoma | 237 | 29.2 | 5.2 | (19.0 – 39.4) | 75 | N/A | N/A | (N/A – N/A) |
| Oregon | 183 | 38.6 | 7.4 | (24.1 – 53.1) | 50 | 47.5 | 13.3 | (21.4 – 73.6) |
| Pennsylvania | 267 | 35.3 | 5.4 | (24.7 – 45.9) | 68 | 21.4 | 6.2 | (9.2 – 33.6) |
| Rhode Island | 209 | 36.3 | 7.0 | (22.6 – 50.0) | 31 | 53.8 | 11.7 | (30.9 – 76.7) |
| Texas | 234 | 32.4 | 7.0 | (18.7 – 46.1) | 66 | 48.2 | 13.6 | (21.5 – 74.9) |
| Utah | 323 | 20.8 | 4.6 | (11.8 – 29.8) | 111 | 24.6 | 6.3 | (12.3 – 36.9) |
| Vermont | 201 | 28.9 | 5.5 | (18.1 – 39.7) | 59 | N/A | N/A | (N/A – N/A) |
| Washington | 295 | 31.4 | 4.8 | (22.0 – 40.8) | 92 | N/A | N/A | (N/A – N/A) |
| West Virginia | 123 | 35.4 | 5.9 | (23.8 – 47.0) | 21 | N/A | N/A | (N/A – N/A) |
| Wisconsin | 191 | 25.5 | 5.8 | (14.1 – 36.9) | 38 | N/A | N/A | (N/A – N/A) |
| Puerto Rico | 246 | 41.5 | 5.7 | (30.3 – 52.7) | 65 | 38.6 | 9.3 | (20.4 – 56.8) |
| 38 state total | 9,385 | 36.4 | 1.5 | (33.5 – 39.3) | 2,352 | 28.8 | 3.2 | (22.5 – 35.1) |
| Median | 35.4 | 41.5 | ||||||
| Range | 20.8-50.3 | 21.4-53.8 | ||||||
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30